Frontiers in Molecular Biosciences

Scope & Guideline

Unlocking the Secrets of Molecular Life

Introduction

Welcome to the Frontiers in Molecular Biosciences information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Frontiers in Molecular Biosciences, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherFRONTIERS MEDIA SA
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationFRONT MOL BIOSCI / Front. Mol. Biosci.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressAVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND

Aims and Scopes

The journal "Frontiers in Molecular Biosciences" aims to advance our understanding of molecular mechanisms underlying biological processes and diseases. It encompasses a broad range of research areas, methodologies, and applications, emphasizing molecular biosciences in health and disease.
  1. Molecular Mechanisms of Disease:
    Research focused on elucidating the molecular pathways involved in various diseases, including cancer, neurodegenerative disorders, and metabolic diseases.
  2. Biomarker Discovery and Validation:
    Studies aimed at identifying and validating novel biomarkers for disease diagnosis, prognosis, and therapeutic response.
  3. Therapeutic Interventions and Drug Development:
    Exploration of innovative therapeutic strategies, including drug repurposing, small molecule inhibitors, and gene therapies, aimed at treating various diseases.
  4. Bioinformatics and Computational Biology:
    Utilization of bioinformatics tools and computational models to analyze biological data, predict interactions, and understand disease mechanisms.
  5. Nanotechnology and Drug Delivery Systems:
    Development of advanced nanocarriers and drug delivery systems to enhance the efficacy of therapeutic agents.
  6. Cellular and Molecular Biology Techniques:
    Application of cutting-edge techniques such as CRISPR, RNA sequencing, and proteomics to study cellular functions and interactions.
The journal has seen a significant rise in topics related to emerging technologies and innovative approaches in molecular biosciences. These trends reflect the current focus on precision medicine, personalized therapies, and the integration of multi-omics data.
  1. Ferroptosis and its Role in Cancer:
    Research exploring the mechanisms of ferroptosis and its implications for cancer therapy is rapidly gaining traction, highlighting its potential as a therapeutic target.
  2. Machine Learning and AI in Biomedical Research:
    The application of machine learning and artificial intelligence to predict molecular interactions, analyze large datasets, and enhance drug discovery is becoming increasingly prominent.
  3. Extracellular Vesicles in Disease Mechanisms:
    Studies focusing on the role of extracellular vesicles in intercellular communication and their implications in various diseases are on the rise, emphasizing their potential as biomarkers and therapeutic targets.
  4. Non-Coding RNAs in Therapeutics:
    Research into the roles of long non-coding RNAs and microRNAs in gene regulation and disease progression is expanding, reflecting their therapeutic potential.
  5. Immunotherapy and Tumor Microenvironment Studies:
    Investigations into the tumor microenvironment and its role in immunotherapy response are trending, with a focus on understanding immune cell infiltration and interactions.

Declining or Waning

While "Frontiers in Molecular Biosciences" continues to publish a diverse array of research, certain themes have shown a decline in prominence over recent years. This may reflect evolving research interests and technological advancements.
  1. Traditional Biochemical Assays:
    As molecular and computational techniques advance, traditional biochemical assays have become less favored, with researchers opting for more innovative approaches.
  2. Single-Domain Antibodies:
    Research on single-domain antibodies has decreased as interest shifts toward more complex antibody formats and engineered therapeutic proteins.
  3. Basic Protein Structure Analysis:
    With the rise of advanced computational modeling and machine learning techniques, basic structural analysis of proteins is receiving less attention in favor of more integrative approaches.
  4. Animal Models in Drug Testing:
    The reliance on animal models for drug testing is waning as ethical considerations and the development of in vitro and computational models gain traction.

Similar Journals

BioImpacts

Bridging knowledge gaps in biochemistry and genetics.
Publisher: TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICESISSN: 2228-5652Frequency: 4 issues/year

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

Biochemistry Research International

Connecting researchers with cutting-edge findings in biochemistry.
Publisher: HINDAWI LTDISSN: 2090-2247Frequency: 1 issue/year

Biochemistry Research International is a prominent and dynamic journal published by Hindawi Ltd, dedicated to advancing knowledge in the field of biochemistry. With its Open Access model established since 2010, the journal provides unrestricted access to high-quality research, thereby fostering global communication among researchers and professionals. Operating out of the United States, Biochemistry Research International serves as a vital platform for disseminating cutting-edge findings in biochemistry and molecular biology, holding a respectable Q2 ranking in its category as of 2023. The journal's scope encompasses a wide array of topics including but not limited to biochemical processes, genetic engineering, and molecular interactions, making it an essential resource for students and seasoned researchers alike. With an impact factor reflective of its significance in the academic community, Biochemistry Research International continues to play an integral role in shaping the future of biochemistry research.

BIOCELL

Exploring the Depths of Biochemistry and Genetics
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Advancing the Frontiers of Human Genetics
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

MOLECULAR AND CELLULAR PROBES

Connecting Researchers to Cutting-edge Cellular Science
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0890-8508Frequency: 6 issues/year

MOLECULAR AND CELLULAR PROBES, published by Academic Press Ltd - Elsevier Science Ltd, stands as a prominent journal at the intersection of cell and molecular biology. With an ISSN of 0890-8508 and an E-ISSN of 1096-1194, this journal has consistently contributed to the scientific discourse since its inception in 1987, converging its scholarly content through to 2024. As a member of Q3 in both Cell Biology and Molecular Biology categories, it provides a platform for innovative research and critical insights into cellular mechanisms, signaling pathways, and molecular interactions. Its Scopus rankings position it within the top half of its categories, fostering a vibrant academic community that supports the exploration and advancement of biochemistry, genetics, and molecular biology. Although it does not currently offer Open Access, the high-quality peer-reviewed articles published in MOLECULAR AND CELLULAR PROBES are invaluable resources for researchers, professionals, and students who seek to stay at the forefront of breakthroughs in these essential fields.

Molecular Biomedicine

Unraveling Biochemical Mysteries for Better Health
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Molecular Biomedicine is a prestigious peer-reviewed journal published by SpringerNature, dedicated to advancing the fields of molecular biology and molecular medicine. With a commendable Q1 ranking in both categories for 2023, this journal stands out for its rigorous exploration of the biochemical processes underlying health and disease. Operating out of Germany, Molecular Biomedicine aims to provide comprehensive insights into cutting-edge research, facilitating interdisciplinary collaboration among researchers, healthcare professionals, and students alike. The journal's impact is reflected in its Scopus rankings, placing it in the upper echelons of the fields of biochemistry, genetics, and molecular biology. As an open access platform, it commits to disseminating knowledge widely, ensuring that pivotal discoveries are accessible to all. Researchers looking to publish in a dynamic environment that prioritizes innovation and application in the biomedical sciences will find Molecular Biomedicine an ideal outlet for their work.

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS

Showcasing cutting-edge research for a global audience.
Publisher: NATL INST SCIENCE COMMUNICATION-NISCAIRISSN: 0301-1208Frequency: 6 issues/year

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS is a well-regarded academic journal that serves as a vital platform for researchers in the fields of biochemistry and biophysics. Published by the NATL INST SCIENCE COMMUNICATION-NISCAIR since its inception in 1972, this Open Access journal has committed itself to disseminating high-quality research and advancements in these dynamic fields, allowing readers worldwide to access vital findings since 2009. The journal maintains a robust presence in the academic landscape, achieving noteworthy rankings in 2023, placing it in the Q4 category for Biochemistry and Q3 for both Biophysics and miscellaneous Medicine, alongside its respectable Scopus rankings. With an emphasis on original research articles, reviews, and educational contributions, the INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS plays an essential role in fostering scientific dialogue and collaboration among professionals and students alike. For scholars seeking to stay at the forefront of biochemistry and biophysics research, this journal is an indispensable resource that fosters knowledge exchange and elevates the field on both a national and international scale.

BMC Molecular and Cell Biology

Unleashing innovative research in molecular and cell biology.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

CURRENT MOLECULAR MEDICINE

Advancing the Frontiers of Molecular Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1566-5240Frequency: 10 issues/year

CURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Unlocking the Secrets of Life at the Cellular Level
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1357-2725Frequency: 12 issues/year

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.